In the BLT-derived GBM8 tumor, human immune cells were detectable, with CD56+ NK cells (0.29%), CD11c+ DCs (0.11%), CD68+ macrophages (0.08%), and T lymphocytes (0.12%) constituting the immune landscape (Figure 3A). The gene discussed is ITGAX; the disease is neoplasm.